These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7115121)

  • 1. Decision-making factors in the adjuvant treatment of operable breast cancer.
    Ahmann FR
    Ariz Med; 1982 Jun; 39(6):383-4, 389. PubMed ID: 7115121
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy of breast cancer.
    Bonadonna G
    Br J Hosp Med; 1980 Jan; 23(1):40, 45, 48 passim. PubMed ID: 6986934
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic factors in the drug therapy of metastasizing breast cancer].
    Mörz R; Schemper M; Bettelheim P; Breyer S; Francesconi M; Graninger W; Jakesz R; Kolb R; Micksche M; Rainer H; Reiner G; Moser K
    Acta Med Austriaca Suppl; 1979; 6():319-22. PubMed ID: 299219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of estrogen receptor status on response to combination chemotherapy for recurrent breast cancer.
    Mortimer J; Reimer R; Greenstreet R; Groppe C; Bukowski R
    Cancer Treat Rep; 1981; 65(9-10):763-6. PubMed ID: 7273011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in multimodal therapy for resectable breast cancer.
    Bonadonna G
    Isr J Med Sci; 1981; 17(9-10):916-21. PubMed ID: 7309481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications and prospects of adjuvant therapy of breast carcinoma].
    Lopez M
    Clin Ter; 1983 Jan; 104(1):59-66. PubMed ID: 6825415
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer of the breast: the past decade (second of two parts).
    Henderson IC; Canellos GP
    N Engl J Med; 1980 Jan; 302(2):78-90. PubMed ID: 7350436
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical treatment for advanced breast cancer.
    Carbone PP; Davis TE
    Semin Oncol; 1978 Dec; 5(4):417-27. PubMed ID: 366755
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between estrogen-receptor proteins and response to chemotherapy in breast cancer.
    Levine RM; Lippman ME
    Cancer Treat Rep; 1984 Apr; 68(4):573-6. PubMed ID: 6370427
    [No Abstract]   [Full Text] [Related]  

  • 10. [The contribution of estrogen receptors in the therapeutic strategy of breast cancer].
    Paridaens R; Sylvester R; Ferrazzi E; Legros N; Leclercq G; Heuson JC
    Gynakol Rundsch; 1981; 21 Suppl 1():87-100. PubMed ID: 7239346
    [No Abstract]   [Full Text] [Related]  

  • 11. Venous thrombosis during multimodal treatment of primary breast carcinoma.
    Weiss RB; Tormey DC; Holland JF; Weinberg VE
    Cancer Treat Rep; 1981; 65(7-8):677-9. PubMed ID: 7248984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
    Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer trends: surgical adjuvant chemotherapy for operable breast cancer.
    Horsley JS; Diasio RB
    Va Med; 1980 Nov; 107(11):781-4. PubMed ID: 7434892
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making.
    Chao C; Studts JL; Abell T; Hadley T; Roetzer L; Dineen S; Lorenz D; YoussefAgha A; McMasters KM
    J Clin Oncol; 2003 Dec; 21(23):4299-305. PubMed ID: 14581440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIH consensus-development statement. Adjuvant chemotherapy of breast cancer. The NIH Consensus-Development Panel.
    N Engl J Med; 1980 Oct; 303(14):831-2. PubMed ID: 6997737
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network].
    Bachelot T; Ray-Coquard I; Coeffic D; Barletta H; Gouttebel MC; Mayer B; Muron T; Laroche GD; Vincent M; Farsi F; Philip T
    Bull Cancer; 2002 Oct; 89(10):897-903. PubMed ID: 12441282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.